Risk factors for progressive axonal degeneration of the retinal nerve fibre layer in multiple sclerosis patients

Department of Ophthalmology, Miguel Servet University Hospital, Zaragoza, Spain.
The British journal of ophthalmology (Impact Factor: 2.98). 07/2011; 95(11):1577-82. DOI: 10.1136/bjo.2010.199232
Source: PubMed


To quantify structural and functional degeneration in the retinal nerve fibre layer (RNFL) of patients with multiple sclerosis (MS) over a 2-year time period, and to analyse the effect of prior optic neuritis (ON) as well as the duration and incidence of MS relapses.
166 MS patients and 120 healthy controls underwent assessment of visual acuity and colour vision, visual field examination, optical coherence tomography, scanning laser polarimetry and visual evoked potentials (VEPs). All subjects were re-evaluated after a period of 12 and 24 months.
Changes in the optic nerve were detected by structural measurements but not by functional assessments. Changes registered in MS patients were greater than changes in healthy controls (p<0.05). Eyes with previous ON showed a greater reduction of parameters in the baseline evaluation, but RNFL atrophy was not significantly greater in the longitudinal study. Patients with MS relapses showed a greater reduction of RNFL thickness and VEP amplitude compared with non-relapsing cases. Patients with and without treatment showed similar measurement reduction, but the non-treated group had a significantly higher increase in Expanded Disability Status Scale (p=0.029).
MS causes progressive axonal loss in the optic nerve, regardless of a history of ON. This ganglion cell atrophy occurs in all eyes but is more marked in MS eyes than in healthy eyes.

2 Reads
  • Fuel and Energy Abstracts 11/2011; 86(11):347-350. DOI:10.1016/j.oftal.2011.10.003
  • [Show abstract] [Hide abstract]
    ABSTRACT: To calculate and validate a linear discriminant function (LDF) for spectral-domain optical coherence tomography (OCT) to improve the diagnostic ability of retinal nerve fiber layer (RNFL) thickness parameters for the detection of multiple sclerosis (MS). Observational cross-sectional study. Patients with multiple sclerosis (n = 115) and age-matched healthy subjects (n = 115) were enrolled in the study. The Spectralis OCT system (Heidelberg Engineering, Heidelberg, Germany) was used to obtain the circumpapillary RNFL thickness in both eyes of each participant. A validating set including 60% of the study subjects (69 healthy individuals and 69 patients with MS) was used to test the performance of the LDF in an independent population. Receiver operating characteristic (ROC) curves were plotted and compared with the RNFL parameters measured using OCT. Sensitivity and specificity were used to evaluate diagnostic performance. The optimized function was 4.965 - 0.40 × (mean thickness 15-30 degrees) - 0.17 × (mean thickness 300-315 degrees) + 2.743 - 0.032 × (mean thickness 105-120 degrees) - 0.031 × (mean thickness 120-135 degrees) - 0.018 × (mean thickness 225-240 degrees). The largest area under the ROC curve was 0.834 for our LDF in the validating population. At 95% fixed specificity, the LDF yielded the highest sensitivity values. Measurements of RNFL thickness obtained with Spectralis OCT had good ability to differentiate between healthy individuals and individuals with MS. On the basis of the area under the ROC curve, the LDF performed better than any single parameter.
    Ophthalmology 04/2012; 119(8):1705-11. DOI:10.1016/j.ophtha.2012.01.046 · 6.14 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: To evaluate and compare the ability of 3 protocols of Fourier-domain optical coherence tomography (OCT) to detect retinal thinning and retinal nerve fiber layer (RNFL) atrophy in patients with Parkinson's disease (PD) compared with healthy subjects. To test the intrasession reproducibility of RNFL thickness measurements in patients with PD and healthy subjects using the Cirrus (Carl Zeiss Meditec Inc., Dublin, CA) and Spectralis (Heidelberg Engineering, Inc., Heidelberg, Germany) OCT devices. Observational, cross-sectional study. Patients with PD (n = 75) and age-matched healthy subjects (n = 75) were enrolled. All subjects underwent three 360-degree circular scans centered on the optic disc by the same experienced examiner using the Cirrus OCT instrument, the classic glaucoma application, and the new Nsite Axonal Analytics of the Spectralis OCT instrument. Differences between the eyes of healthy subjects and the eyes of patients with PD were compared using the 3 protocols. The relationship between measurements provided by each OCT protocol was evaluated. Repeatability was studied by intraclass correlation coefficients and coefficients of variation. Retinal nerve fiber layer atrophy was detected in eyes of patients with PD (P = 0.025, P=0.042, and P < 0.001) with the 3 protocols used, but the Nsite Axonal Analytics of the Spectralis OCT device was the most sensitive for detecting subclinical defects. In eyes of patients with PD, RNFL thickness measurements determined by the OCT devices were correlated, but they were significantly different between the Cirrus and Spectralis devices (P = 0.038). Reproducibility was good with all 3 protocols but better using the Glaucoma application of the Spectralis OCT device. Fourier-domain OCT can be considered a valid and reproducible device for detecting subclinical RNFL atrophy in patients with PD, especially the Nsite Axonal Analytics of the Spectralis device. Retinal nerve fiber layer thickness measurements differed significantly between the Cirrus and Spectralis devices despite a high correlation of the measurements between the 2 instruments. The author(s) have no proprietary or commercial interest in any materials discussed in this article.
    Ophthalmology 06/2012; 119(10):2161-7. DOI:10.1016/j.ophtha.2012.05.003 · 6.14 Impact Factor
Show more